Which pen delivers growth hormone better? new study aims to find out
NCT ID NCT07542886
First seen Apr 22, 2026 · Last updated May 20, 2026 · Updated 8 times
Summary
This study tests two different injector pens that deliver the same medicine (Genotropin) under the skin. Researchers want to see if both pens work the same way in healthy adults aged 18 to 60. Participants will receive one dose with each pen and have blood samples taken to measure medicine levels. The study lasts about 10 weeks and includes a 13-day stay at the clinic.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Pfizer Clinical Research Unit - Brussels
RECRUITINGBrussels, Bruxelles-capitale, Région de, B-1070, Belgium
Conditions
Explore the condition pages connected to this study.